Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Items 101–200 of 1,010
Bao, W., Bussel, J. B., Heck, S., He, W., Karpoff, M., Boulad, N., & Yazdanbakhsh, K. (2010) · Blood · doi:10.1182/blood-2010-04-281717 · Cited by 345
T-cell regulation: with complements from innate immunity
Kemper, C., & Atkinson, J. P. (2007) · Nature Reviews Immunology · doi:10.1038/nri1994 · Cited by 340
“These natural T Reg cells constitutively express the transcription factor forkhead box P3 ( FOXP3 ) and the IL-2 receptor α-chain (CD25), and require exogenous IL-2 for their function and expansio”
BackgroundInhibitory Effects of B Cells on Antitumor Immunity
Inoue, S., Leitner, W. W., Golding, B., & Scott, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3766 · Cited by 337
“This observation leads to the question of whether eliminating CD25CD4 regulatory T-cell functions may be useful in cancer immune therapies (26).”
BackgroundVaccines for tumour prevention
Lollini, P.-L., Cavallo, F., Nanni, P., & Forni, G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1815 · Cited by 340
“These findings fit in well with the burgeoning data on the role of T reg cells in controlling the reaction against self antigen”
ResultRegulatory T Cells Ameliorate Angiotensin II–Induced Cardiac Damage
Kvakan, H., Kleinewietfeld, M., Qadri, F., Park, J.-K., Fischer, R., Schwarz, I., Rahn, H.-P., Plehm, R., Wellner, M., Elitok, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.832782 · Cited by 339
The development and function of regulatory T cells
Workman, C. J., Szymczak-Workman, A. L., Collison, L. W., Pillai, M. R., & Vignali, D. A. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0026-2 · Cited by 344
“of nTregs in the thymus and periphery [51, 52].”
Transient regulatory T-cells: A state attained by all activated human T-cells
Pillai, V., Ortega, S. B., Wang, C. K., & Karandikar, N. J. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.10.014 · Cited by 339
“Natural CD4+CD25+FOXP3+ Tregs are thought to arise in the thymus and suppress harmful immune responses in the periphery [1].”
BackgroundEtiopathogenesis of inflammatory bowel diseases
Danese, S., & Fiocchi, C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.12.4807 · Cited by 327
The Akt pathway in oncology therapy and beyond (Review)
Nitulescu, G., Van De Venter, M., Nitulescu, G., Ungurianu, A., Juzenas, P., Peng, Q., Olaru, O., Grădinaru, D., Tsatsakis, A., Tsoukalas, D., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4597 · Cited by 328
Immune microenvironments in solid tumors: new targets for therapy
Shiao, S. L., Ganesan, A. P., Rugo, H. S., & Coussens, L. M. (2011) · Genes & Development · doi:10.1101/gad.169029.111 · Cited by 322
Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling
Zanin-Zhorov, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28423 · Cited by 323
RetractedTranscriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance
Kallies, A., Hawkins, E. D., Belz, G. T., Metcalf, D., Hommel, M., Corcoran, L. M., Hodgkin, P. D., & Nutt, S. L. (2006) · Nature Immunology · doi:10.1038/ni1321 · Cited by 317
“Finally, regulatory T cells (T reg cells) provide another essential means of preventing autoimmunity by limiting immune responses to self and foreign antigen”
BackgroundHTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001274 · Cited by 319
“HBZ inhibits Foxp3-mediated CTLA-4 and GITR expression in CD4+ T cells in vitro In HBZ-Tg mice, the expression of Treg-associated molecules including CTLA-4, GITR and CD25 was suppressed when compared with their expression in Treg cells from non-Tg mice (Figure 3B and E).”
BackgroundInfluentialSelf-citationTGFβ signalling in control of T-cell-mediated self-reactivity
Rubtsov, Y. P., & Rudensky, A. Y. (2007) · Nature Reviews Immunology · doi:10.1038/nri2095 · Cited by 311
“These cells play a crucial role in suppressing overexuberant immune responses during infection and are needed continuously to keep in check T cells that are reactive to self and environmental antigen”
Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension
Tamosiuniene, R., Tian, W., Dhillon, G., Wang, L., Sung, Y. K., Gera, L., Patterson, A. J., Agrawal, R., Rabinovitch, M., Ambler, K., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.236927 · Cited by 306
Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., & Dhodapkar, K. M. (2006) · Blood · doi:10.1182/blood-2006-03-011353 · Cited by 311
Plasticity of Human CD4 T Cell Subsets
Geginat, J., Paroni, M., Maglie, S., Alfen, J. S., Kastirr, I., Gruarin, P., De Simone, M., Pagani, M., & Abrignani, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00630 · Cited by 292
“Five principal subsets or lineages of CD4 T cells have been identified so far: T helper (Th)1, Th2, and Th17 cells that target specific classes of pathogens (3–5), regulatory T cells that are required to maintain self-tolerance (6) and follicular helper T cells (TFH) that provide help to B cells for antibody productio…”
BackgroundSzczepanski, M. J., Szajnik, M., Czystowska, M., Mandapathil, M., Strauss, L., Welsh, A., Foon, K. A., Whiteside, T. L., & Boyiadzis, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3010 · Cited by 303
“Green, CD4 cells (1 and 4); red, CD25 cells (2 and 5); blue, Foxp3 cells (2); blue, NFAT1 cells (5).”
BackgroundA bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1
Li, W., Hang, S., Fang, Y., Bae, S., Zhang, Y., Zhang, M., Wang, G., McCurry, M. D., Bae, M., Paik, D., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.07.013 · Cited by 306
Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis†
Lan, R. Y., Cheng, C., Lian, Z., Tsuneyama, K., Yang, G., Moritoki, Y., Chuang, Y., Nakamura, T., Saito, S., Shimoda, S., et al. (2006) · Hepatology · doi:10.1002/hep.21123 · Cited by 305
den Brok, M. H. M. G. M., Sutmuller, R. P. M., Nierkens, S., Bennink, E. J., Frielink, C., Toonen, L. W. J., Boerman, O. C., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603341 · Cited by 296
“In situ tumour destruction with cryo, radiofrequency or laser ablation has received increasing attention as a treatment modality for focal cancer (Ruers et al, 2001; Ruers and Bleichrodt, 2002; Curley, 2003; Erce and Parks, 2003; Veth et al, 2005).”
BackgroundImmune regulation by 4‐1BB and 4‐1BBL: complexities and challenges
Wang, C., Lin, G. H. Y., McPherson, A. J., & Watts, T. H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00765.x · Cited by 298
Autoimmunity in Dry Eye Is Due to Resistance of Th17 to Treg Suppression
Chauhan, S. K., El Annan, J., Ecoiffier, T., Goyal, S., Zhang, Q., Saban, D. R., & Dana, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1247 · Cited by 298
“Tregs play a central role in maintaining peripheral tolerance and controlling organ-specific autoimmunity by suppressing pathogenic autoreactive T cells (12, 13).”
BackgroundSkin-resident T cells: the ups and downs of on site immunity
Clark, R. A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.247 · Cited by 298
“Tregs are critical to the development and maintenance of selftolerance and function by suppressing the activation, cytokine production, and proliferation of other T cells (Sakaguchi, 2005).”
BackgroundThe immunology of pregnancy: Regulatory T cells control maternal immune tolerance toward the fetus
La Rocca, C., Carbone, F., Longobardi, S., & Matarese, G. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.06.013 · Cited by 288
“Treg cells are a small subset of T cells, usually constituting about 5–15% of the peripheral CD4 + T cell compartment in mice and humans [14-16].”
Rech, A. J., & Vonderheide, R. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04939.x · Cited by 289
Diehl, L., Schurich, A., Grochtmann, R., Hegenbarth, S., Chen, L., & Knolle, P. A. (2008) · Hepatology · doi:10.1002/hep.21965 · Cited by 291
The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function
Pompura, S. L., & Dominguez-Villar, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0817-349r · Cited by 288
Scleroderma: from cell and molecular mechanisms to disease models
Abraham, D. J., & Varga, J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.09.004 · Cited by 283
Cardone, J., Le Friec, G., Vantourout, P., Roberts, A., Fuchs, A., Jackson, I., Suddason, T., Lord, G., Atkinson, J. P., Cope, A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1917 · Cited by 284
“However, uncertainty as to the nature of critical IL-10-producing cells in vivo , particularly in humans, has been fueled by the realization that under certain conditions, large amounts of IL-10 can be secreted by some natural T reg cell”
Kondělková, K., Vokurková, D., Krejsek, J., Borská, L., Fiala, Z., & Andrýs, C. (2010) · Acta Medica (Hradec Kralove, Czech Republic) · doi:10.14712/18059694.2016.63 · Cited by 276
“It is a difficult task to identify Treg cells by flow cytometry, as the most specific marker FoxP3 is localized intracellulary (5, 6, 29).”
BackgroundHuman natural Treg microRNA signature: Role of microRNA‐31 and microRNA‐21 in FOXP3 expression
Rouas, R., Fayyad‐Kazan, H., El Zein, N., Lewalle, P., Rothé, F., Simion, A., Akl, H., Mourtada, M., El Rifai, M., Burny, A., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838509 · Cited by 283
Chen, X., Zhou, B., Li, M., Deng, Q., Wu, X., Le, X., Wu, C., Larmonier, N., Zhang, W., Zhang, H., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.11.009 · Cited by 283
Nakae, S., Iwakura, Y., Suto, H., & Galli, S. J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006610 · Cited by 282
“T-bet, GATA-3, or Foxp3 participates in the development of Th1, Th2, or Tr1 cells, respectively [36, 37].”
BackgroundAdult Autoimmune Enteropathy: Mayo Clinic Rochester Experience
Akram, S., Murray, J. A., Pardi, D. S., Alexander, G. L., Schaffner, J. A., Russo, P. A., & Abraham, S. C. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.013 · Cited by 287
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Ghiringhelli, F., Ménard, C., Martin, F., & Zitvogel, L. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00445.x · Cited by 273
“Recently, mouse and human Tregs were found to express forkhead box protein 3 (Foxp3), a specific transcription factor that controls both their development and function (38), as shown in foxp3mutant mice, which display a natural deficiency in Tregs and develop a severe lymphoproliferative autoimmune syndrome.”
BackgroundTakahashi, R., Kano, Y., Yamazaki, Y., Kimishima, M., Mizukawa, Y., & Shiohara, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804002 · Cited by 276
“evidence indicating the roles of viruses (13) and Treg cells (14) in”
BackgroundTorgerson, T. R., Linane, A., Moes, N., Anover, S., Mateo, V., Rieux–Laucat, F., Hermine, O., Vijay, S., Gambineri, E., Cerf–Bensussan, N., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.044 · Cited by 272
IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer
Kryczek, I., Wu, K., Zhao, E., Wei, S., Vatan, L., Szeliga, W., Huang, E., Greenson, J., Chang, A., Roliński, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003251 · Cited by 264
Emerging avenues linking inflammation and cancer
Kundu, J. K., & Surh, Y.-J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.035 · Cited by 264
“While a subset of regulatory T lymphocytes (Foxp3/CD4) can inhibit immune responses and temper inflammation [114], Th17 cells (IL-17/CD4) are known to mediate inflammation [115].”
BackgroundCD25+/Foxp3+ T Cells Regulate Gastric Inflammation and Helicobacter pylori Colonization In Vivo
Rad, R., Brenner, L., Bauer, S., Schwendy, S., Layland, L., da Costa, C. P., Reindl, W., Dossumbekova, A., Friedrich, M., Saur, D., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.001 · Cited by 272
Venken, K., Hellings, N., Broekmans, T., Hensen, K., Rummens, J.-L., & Stinissen, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6411 · Cited by 259
“Numerous studies have indicated their role in the prevention of detrimental autoimmunity in animal models (1).”
BackgroundThe regulation of allergy and asthma
Umetsu, D. T., & DeKruyff, R. H. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00413.x · Cited by 266
Regulatory T cells in immune surveillance and treatment of cancer
Yamaguchi, T., & Sakaguchi, S. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.11.005 · Cited by 263
Self-citationc-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells
Isomura, I., Palmer, S., Grumont, R. J., Bunting, K., Hoyne, G., Wilkinson, N., Banerjee, A., Proietto, A., Gugasyan, R., Wu, L., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091411 · Cited by 253
“…T reg cells Although thymus-derived CD4+Foxp3+ T cells are the major source of T reg cells (Fontenot and Rudensky, 2005; Fontenot et al., 2005a; Sakaguchi, 2005; Ziegler, 2006), the TGF-– induced differentiation of CD4+CD25 T cells into T reg cells (Chen et al., 2003; Marie et al., 2005),…”
BackgroundInfluentialPutnam, A. L., Safinia, N., Medvec, A., Laszkowska, M., Wray, M., Mintz, M. A., Trotta, E., Szot, G. L., Liu, W., Lares, A., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12433 · Cited by 261
Beers, D. R., Zhao, W., Wang, J., Zhang, X., Wen, S., Neal, D., Thonhoff, J. R., Alsuliman, A. S., Shpall, E. J., Rezvani, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89530 · Cited by 254
FOXP3 modifies the phenotypic and functional properties of regulatory T cells
Campbell, D. J., & Ziegler, S. F. (2007) · Nature Reviews Immunology · doi:10.1038/nri2061 · Cited by 261
Couper, K. N., Blount, D. G., Wilson, M. S., Hafalla, J. C., Belkaid, Y., Kamanaka, M., Flavell, R. A., de Souza, J. B., & Riley, E. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000004 · Cited by 258
“Although first identified as cells that limit autoimmune pro-inflammatory responses [14], nTreg (defined by expression of CD4, the transcription factor Foxp3”
BackgroundLevels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation
Chauhan, S. K., Saban, D. R., Lee, H. K., & Dana, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.148 · Cited by 257
“Amongst the various forms of regulatory T cells, CD4+CD25+ regulatory T cells (Tregs), which constitute 5-10% of CD4+ T cells, play a central role in inducing and maintaining tolerance to both self- and allo-antigens (1-3).”
BackgroundGao, W., Lu, Y., El Essawy, B., Oukka, M., Kuchroo, V. K., & Strom, T. B. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01842.x · Cited by 260
“These thymus-derived cells are essential in maintaining self-tolerance (4), and are also indispensable for induction of peripheral tolerance in animal models of transplantation (5).”
BackgroundT Cells in Atherogenesis: For Better or For Worse?
Robertson, A.-K. L., & Hansson, G. K. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000245830.29764.84 · Cited by 252
Yamazaki, S., Inaba, K., Tarbell, K. V., & Steinman, R. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00422.x · Cited by 259
Kavanagh, B., O'Brien, S., Lee, D., Hou, Y., Weinberg, V., Rini, B., Allison, J. P., Small, E. J., & Fong, L. (2008) · Blood · doi:10.1182/blood-2007-11-125435 · Cited by 256
Zeng, C., Shi, X., Zhang, B., Liu, H., Zhang, L., Ding, W., & Zhao, Y. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0816-5 · Cited by 245
Ordway, D., Henao-Tamayo, M., Harton, M., Palanisamy, G., Troudt, J., Shanley, C., Basaraba, R. J., & Orme, I. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.522 · Cited by 259
Regulatory T cells in virus infections
Rouse, B. T., Sarangi, P. P., & Suvas, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00412.x · Cited by 255
“Moreover, when such cells were present, the inflammatory effects of autoreactive T cells could be modulated both in vitro and in vivo (4, 6).”
BackgroundHaas, J., Fritzsching, B., Trübswetter, P., Korporal, M., Milkova, L., Fritz, B., Vobis, D., Krammer, P. H., Suri-Payer, E., & Wildemann, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1322 · Cited by 249
“Because only CD4 T cells expressing the FOXP3 gene product scurfin exhibit suppressive function (24), CD4 CD25 FOXP3 cells were defined as Treg and CD4 FOXP3 cells as Th (Fig.”
BackgroundSegundo, D. S., Ruiz, J. C., Izquierdo, M., Fernández-Fresnedo, G., Gómez-Alamillo, C., Merino, R., Benito, M. J., Cacho, E., Rodrigo, E., Palomar, R., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000229473.95202.50 · Cited by 249
“Recent evidence indicates that CD4 CD25 regulatory T cells (Tregs) have a crucial role in the mechanisms of immune tolerance (5).”
BackgroundThe Tumor Microenvironment in Colorectal Carcinogenesis
Peddareddigari, V. G., Wang, D., & DuBois, R. N. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0038-3 · Cited by 237
“macrophages can directly induce T-regulatory (Treg) cells by cell–cell contact via membrane-bound TGF-β1 expressed on the Treg cells [46, 92], resulting in suppression of antitumor T-cells and other inflammatory cells such as monocytes [93, 94].”
BackgroundAutoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Friese, M. A., & Fugger, L. (2005) · Brain · doi:10.1093/brain/awh578 · Cited by 251
“In contrast to CD4 + regulatory T cells which are now relatively well characterized in their expression of CD25 and Foxp3 (Sakaguchi, 2005) and which have been reported to show a decrease in their function from peripheral blood of patients with multiple sclerosis as compared with healthy donors…”
InfluentialThe Inflammatory Tumor Microenvironment and Its Impact on Cancer Development
de Visser, K. E., & Coussens, L. M. (2006) · Contributions to Microbiology · doi:10.1159/000092969 · Cited by 247
Regulatory T cells in patients with systemic lupus erythematosus
Alvarado-Sánchez, B., Hernández-Castro, B., Portales-Pérez, D., Baranda, L., Layseca-Espinosa, E., Abud-Mendoza, C., Cubillas-Tejeda, A. C., & González-Amaro, R. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.06.005 · Cited by 246
Waldmann, T. A. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0009 · Cited by 238
“Several lines of evidence support amodel inwhich this interaction suppresses IL2 and IFNg production, upregulates Treg-associatedmolecules, and exerts suppressive activity (28).”
BackgroundExperimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS)
Glatigny, S., & Bettelli, E. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028977 · Cited by 247
“During active EAE, Tregs are believed to ameliorate disease progression through the control of effector T cells (Kohm et al. 2002; Zhang et al. 2004; Reddy et al. 2005; Sakaguchi 2005; Stephens et al. 2009; Koutrolos et al. 2014).”
BackgroundEmerging Challenges in Regulatory T Cell Function and Biology
Sakaguchi, S., & Powrie, F. (2007) · Science · doi:10.1126/science.1142331 · Cited by 245
Self-citationChen, K.-J., Lin, S.-Z., Zhou, L., Xie, H.-Y., Zhou, W.-H., Taki-Eldin, A., & Zheng, S.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024671 · Cited by 240
“Overall, Treg-cell-mediated immunosuppression is one of the crucial tumor immune-evasion mechanisms and the main obstacle of successful tumor immunotherapy [1,8,9].”
BackgroundHow do CD4+CD25+ regulatory T cells control autoimmunity?
Bluestone, J. A., & Tang, Q. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.09.002 · Cited by 245
The decidua—the maternal bed embracing the embryo—maintains the pregnancy
Mori, M., Bogdan, A., Balassa, T., Csabai, T., & Szekeres-Bartho, J. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0574-0 · Cited by 232
“during pregnancy, under a certain condition, Treg cells can also contribute to maternal tolerance of the fetus via producing IL10 [126, 127].”
Backgroundde Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M., & van der Wal, A. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000779 · Cited by 237
“Regulatory T cells play a central role in inducing and maintaining immunologic tolerance and the termination of immune responses, and deficiency or dysfunction of these cells lead to autoimmunity or aggravated pathogen-induced inflammation[8,9].”
BackgroundCohen, A. C., Nadeau, K. C., Tu, W., Hwa, V., Dionis, K., Bezrodnik, L., Teper, A., Gaillard, M., Heinrich, J., Krensky, A. M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2770 · Cited by 235
Wei, J., Duramad, O., Perng, O. A., Reiner, S. L., Liu, Y.-J., & Qin, F. X.-F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703642104 · Cited by 239
Yu, J., Heck, S., Patel, V., Levan, J., Yu, Y., Bussel, J. B., & Yazdanbakhsh, K. (2008) · Blood · doi:10.1182/blood-2008-01-135335 · Cited by 238
Dysfunctional T regulatory cells in multiple myeloma
Prabhala, R. H., Neri, P., Bae, J. E., Tassone, P., Shammas, M. A., Allam, C. K., Daley, J. F., Chauhan, D., Blanchard, E., Thatte, H. S., et al. (2006) · Blood · doi:10.1182/blood-2005-08-3101 · Cited by 239
Gazzola, L., Tincati, C., Bellistrì, G. M., d’Arminio Monforte, A., & Marchetti, G. (2009) · Clinical Infectious Diseases · doi:10.1086/595851 · Cited by 238
Breous, E., Somanathan, S., Vandenberghe, L. H., & Wilson, J. M. (2009) · Hepatology · doi:10.1002/hep.23043 · Cited by 237
Viral infections as potential triggers of type 1 diabetes
van der Werf, N., Kroese, F. G. M., Rozing, J., & Hillebrands, J. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.695 · Cited by 233
“In vivo, anti-inflammatory cytokines like IL-10 and TGF-β are also required for Treg-mediated suppression [54].”
BackgroundRegulatory T-Cells: Diverse Phenotypes Integral to Immune Homeostasis and Suppression
Peterson, R. A. (2012) · Toxicologic Pathology · doi:10.1177/0192623311430693 · Cited by 230
Liu, S., Foulkes, W. D., Leung, S., Gao, D., Lau, S., Kos, Z., & Nielsen, T. O. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0432-8 · Cited by 236
“This transcription factor plays an important role in the development and function of immune regulatory T cells (Tregs), and can be used as a specific biomarker for the identification of Tregs within an inflammatory infiltrate [2].”
Crellin, N. K., Garcia, R. V., & Levings, M. K. (2007) · Blood · doi:10.1182/blood-2006-07-035279 · Cited by 234
Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment
Gajewski, T. F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0892 · Cited by 230
Ge, Y., Domschke, C., Stoiber, N., Schott, S., Heil, J., Rom, J., Blumenstein, M., Thum, J., Sohn, C., Schneeweiss, A., et al. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1106-3 · Cited by 228
Helicobacter pylori Gastritis in Children Is Associated With a Regulatory T-Cell Response
Harris, P. R., Wright, S. W., Serrano, C., Riera, F., Duarte, I., Torres, J., Peña, A., Rollán, A., Viviani, P., Guiraldes, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.006 · Cited by 237
Chen, C., Rowell, E. A., Thomas, R. M., Hancock, W. W., & Wells, A. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608848200 · Cited by 231
Oo, Y. H., Weston, C. J., Lalor, P. F., Curbishley, S. M., Withers, D. R., Reynolds, G. M., Shetty, S., Harki, J., Shaw, J. C., Eksteen, B., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901216 · Cited by 232
Natural regulatory T cells and self-tolerance
Schwartz, R. H. (2005) · Nature Immunology · doi:10.1038/ni1184 · Cited by 231
PTPN22: Setting thresholds for autoimmunity
Gregersen, P. K., Lee, H.-S., Batliwalla, F., & Begovich, A. B. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.009 · Cited by 229
Larmonier, N., Marron, M., Zeng, Y., Cantrell, J., Romanoski, A., Sepassi, M., Thompson, S., Chen, X., Andreansky, S., & Katsanis, E. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0160-8 · Cited by 225
Bour‐Jordan, H., & Bluestone, J. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00775.x · Cited by 223
Translating Tumor Antigens into Cancer Vaccines
Buonaguro, L., Petrizzo, A., Tornesello, M. L., & Buonaguro, F. M. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00286-10 · Cited by 219
Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
Karin, N., & Razon, H. (2018) · Cytokine · doi:10.1016/j.cyto.2018.02.012 · Cited by 222
“Because Treg cells are the gatekeepers for preventing autoimmunity [75], enhanced immunity that is sufficient to effectively suppress cancer increases the risk for autoimmunity [76–78].”
BackgroundChen, X., Subleski, J. J., Hamano, R., Howard, O. M. Z., Wiltrout, R. H., & Oppenheim, J. J. (2010) · European Journal of Immunology · doi:10.1002/eji.200940022 · Cited by 207
Liu, Y., Li, P., Lu, J., Xiong, W., Oger, J., Tetzlaff, W., & Cynader, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1887 · Cited by 227
Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
Gao, C., Wang, Y., Broaddus, R., Sun, L., Xue, F., & Zhang, W. (2018) · Oncotarget · doi:10.18632/oncotarget.23695 · Cited by 224
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia
Solomou, E. E., Rezvani, K., Mielke, S., Malide, D., Keyvanfar, K., Visconte, V., Kajigaya, S., Barrett, A. J., & Young, N. S. (2007) · Blood · doi:10.1182/blood-2007-01-066258 · Cited by 225
T cell control in autoimmune bullous skin disorders
Hertl, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28547 · Cited by 220
Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice
Liu, G., Ma, H., Qiu, L., Li, L., Cao, Y., Ma, J., & Zhao, Y. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.70 · Cited by 221
“It is now known that CDpCD2p regulatory T cells (Treg cells), which express unique transcription factor Foxp3, can efficiently regulate CDpCD2− T-effector cells, B cells, natural killer cells, dendritic cells, monocytes and neutrophils directly”
BackgroundHofmeister, C. C., Zhang, J., Knight, K. L., Le, P., & Stiff, P. J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705538 · Cited by 219
The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease
Karin, N. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909602 · Cited by 217
“these subsets can be divided into two major categories: those that express Foxp3 (Foxp3 ) and are known as natural Tregs [106, 107] and the antigen-specific Tregs, which are Foxp3 and suppress the function of effector T cells by producing suppressor cytokines, such as TGF- [108, 109], IL-10 [110], and possibly IL-35 […”
Background
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.